Home > Specialists > Pathology > Dr. Rongkui Luo (罗荣奎)
Specialty & Clinical Focus:
Pathologist and Chief Physician at Zhongshan Hospital, Fudan University in Shanghai, specializing in the pathological diagnosis of gastrointestinal, thyroid, breast, lung, neurological and ovarian cancers, soft tissue sarcomas, and the interpretation of immunohistochemistry and genetic testing results.
Professional Title & Qualifications:
Chief Physician, M.D., Ph.D.
Hospital & Department：
Shanghai Zhongshan Hospital, Fudan University – Department of Pathology
(address: No. 180 Fenglin Road, Xuhui District, Shanghai, 200032)
Dr. Rongkui Luo (罗荣奎) - Pathologist
Personal Biography
Dr. Rongkui Luo is a Chief Physician in the Department of Pathology at Zhongshan Hospital, Fudan University in Shanghai. He holds a Ph.D. in Pathology and Pathophysiology from Fudan University and has more than a decade of experience in clinical pathology diagnosis. His clinical focus includes gastrointestinal, thyroid, breast, lung, neurological and ovarian cancers, as well as soft tissue sarcomas. He is a core member of the hospital’s multidisciplinary teams for breast cancer and soft tissue sarcoma and interprets pathology, immunohistochemistry and genetic testing results, with formal certification in PD-L1 interpretation.
Why Choose Dr. Rongkui Luo for Your Pathology Review?
For international patients facing a new, complex or uncertain cancer diagnosis, a specialist pathology review can help clarify the evidence supporting the next stage of care before travel is arranged. Dr. Rongkui Luo combines more than a decade of clinical pathology experience at Zhongshan Hospital, Fudan University with a Ph.D. in Pathology and Pathophysiology and active roles in the hospital’s breast cancer and soft tissue sarcoma multidisciplinary teams.
His practice covers gastrointestinal, thyroid, breast, lung, neurological and ovarian cancers, soft tissue sarcomas, and the interpretation of immunohistochemistry and genetic testing results. This breadth is particularly relevant for patients seeking review of existing pathology reports, slides, immunohistochemistry findings or molecular test results before deciding how to prepare for further care or potential medical travel to China. His PD-L1 interpretation certification and 2019 National Pathology Slide Reading Competition championship provide further evidence of his diagnostic-review experience.
Pre-Travel Case Review & Specialist Liaison
Before planning medical travel to China, international patients can request MedBridgeNZ coordination for a remote specialist pathology review with Dr. Rongkui Luo. We help organise pathology reports, immunohistochemistry and genetic testing records, arrange translation where needed, and coordinate client-authorized document transfer and appointment communication with the relevant specialist office.
Once the review arrangement is confirmed and the required materials have been received, Dr. Luo will review the submitted records and provide his pathology opinion, recommendations and responses to the patient’s prepared questions. This specialist feedback can help the patient and their existing treating team understand the diagnosis more clearly, identify any additional reports or specimens that may be needed, and decide whether further in-person evaluation or medical travel planning in China should be pursued.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Rongkui Luo
Areas of Expertise
Pathological diagnosis of gastric cancer, colorectal cancer, and early digestive tract cancers.
Pathological diagnosis of thyroid and breast cancers.
Pathological diagnosis of lung cancer.
Pathological diagnosis of glioma and meningioma.
Pathological diagnosis of soft tissue sarcoma and ovarian cancer.
Interpretation of pathology, immunohistochemistry, and genetic testing reports.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
2,700 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Chief Physician, Department of Pathology, Zhongshan Hospital, Fudan University, with over a decade of clinical pathology diagnosis experience.
Education & Training
Ph.D., Pathology and Pathophysiology: Fudan University
M.S., Pathology: Fudan University
B.S., Clinical Medicine: Fudan University
Awards & Honors
First Prize, Chinese Journal of Pathology "Pathology Detective" Quiz Competition (2021).
Individual Champion (Shanghai Division) and National Grand Champion, National Pathology Slide Reading Competition, Chinese Medical Association (2019).
Champion (Shanghai Division) and National Runner-up, MDT Competition, Chinese Journal of Laparoscopic Urology (2018).
PD-L1 Interpretation Certified.
Academic & Professional Memberships
Member, Big Data Group, Pathology Professional Committee, China Anti-Cancer Association (CACA).
Member, Precision Medicine Expert Committee, Tumor Rehabilitation Branch, Chinese Society of Gerontology and Geriatrics.
Research & Publications
Selected Peer-Reviewed Publications
Wang Y, Luo R, et al. Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms. Nat Commun. 2023;14(1):505. PMID: 36720864
Tang S, Wang Y, Luo R, et al. Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma. Nat Commun. 2024;15(1):1381. PMID: 38360860
Luo R, Huang W, et al. SP70 is a potential biomarker to identify gastric fundic gland neoplasms. World J Surg Oncol. 2022;20(1):132. PMID: 35468832
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Luo’s pathology expertise relevant to my cancer type?
Dr. Luo’s stated clinical focus includes the pathological diagnosis of gastrointestinal, thyroid, breast, lung and neurological cancers, soft tissue sarcomas and ovarian cancer, together with interpretation of immunohistochemistry and genetic testing results. Before a remote specialist-review request is submitted, MedBridgeNZ can help organise the available pathology reports, slide or specimen information, immunohistochemistry results, molecular test reports and clinical summary. Once the arrangement is confirmed, the submitted materials will be transferred with the patient’s authorization for review within Dr. Luo’s stated pathology scope.
How can I request a remote pathology review with Dr. Luo from outside China?
International patients can request MedBridgeNZ coordination for a remote specialist-review pathway with Dr. Luo. We coordinate medical-record preparation, translation where required, client-authorized transfer of pathology reports, immunohistochemistry and genetic testing results, and appointment communication with the relevant specialist office. Once the review arrangement is confirmed and the requested materials have been received, Dr. Luo will examine the submitted information, provide his pathology opinion and recommendations, and respond to the patient’s prepared questions. The exact records or pathology materials required depend on the case and the specialist office’s instructions.
What happens after Dr. Luo completes the remote pathology review?
After Dr. Luo completes the remote pathology review, the patient receives the specialist’s findings, recommendations and responses to the submitted questions through the coordinated communication pathway. Depending on those findings, the next step may be to discuss the opinion with the patient’s existing treating team, provide additional slides or reports, or consider further hospital evaluation in China. Where the patient wishes to proceed with medical travel, MedBridgeNZ can assist with appointment-request coordination, medical invitation or visa-document support, travel planning, translation coordination and non-clinical bilingual administrative support.
Can Dr. Luo prescribe medication or issue a treatment plan during a remote review?
Dr. Luo’s remote review focuses on pathological diagnosis and interpretation of existing pathology, immunohistochemistry and genetic testing results. He may provide a specialist pathology opinion and recommendations relevant to the case, but prescriptions and formal treatment plans are normally established by the appropriate attending clinician within the relevant care setting. MedBridgeNZ coordinates the administrative pathway, records preparation, translation and communication; it does not provide medical advice, diagnosis or treatment. Where further evaluation in China is recommended, the team can assist with an appointment request and related travel logistics.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider supporting international patients who are exploring specialist-care pathways in China. We assist with appointment-request coordination, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document coordination support, travel planning and non-clinical bilingual administrative support. MedBridgeNZ does not provide medical advice, diagnosis or treatment. Hospital, specialist and other third-party medical or travel costs remain separate from our coordination fees unless a written service description expressly states otherwise.